BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Wang P, Dong C, Zhao Y, Zhou J, Yuan C, Zou L. Mechanisms of ebselen as a therapeutic and its pharmacology applications. Future Med Chem 2020;12:2141-60. [PMID: 33225732 DOI: 10.4155/fmc-2019-0218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Victoni T, Barreto E, Lagente V, Carvalho VF. Oxidative Imbalance as a Crucial Factor in Inflammatory Lung Diseases: Could Antioxidant Treatment Constitute a New Therapeutic Strategy? Oxid Med Cell Longev 2021;2021:6646923. [PMID: 33628371 DOI: 10.1155/2021/6646923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Loreto Palacio P, Godoy JR, Aktas O, Hanschmann EM. Changing Perspectives from Oxidative Stress to Redox Signaling-Extracellular Redox Control in Translational Medicine. Antioxidants (Basel) 2022;11:1181. [PMID: 35740078 DOI: 10.3390/antiox11061181] [Reference Citation Analysis]
3 Fiorito S, Epifano F, Palumbo L, Collevecchio C, Genovese S. A revised version of the Iwaoka’s assay: Application of hyphenated techniques. Journal of Pharmaceutical and Biomedical Analysis 2022;212:114652. [DOI: 10.1016/j.jpba.2022.114652] [Reference Citation Analysis]
4 Longenecker RJ, Gu R, Homan J, Kil J. Development of Tinnitus and Hyperacusis in a Mouse Model of Tobramycin Cochleotoxicity. Front Mol Neurosci 2021;14:715952. [PMID: 34539342 DOI: 10.3389/fnmol.2021.715952] [Reference Citation Analysis]
5 Bjørklund G, Zou L, Wang J, Chasapis CT, Peana M. Thioredoxin reductase as a pharmacological target. Pharmacol Res 2021;174:105854. [PMID: 34455077 DOI: 10.1016/j.phrs.2021.105854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]